All Type of News
Daehwa Pharm. to patent an anti-cancer therapy.
Daehwa pharmaceutical company announced on Dec. 22 that the company developed an application method of Paclitaxel, an anti-cancer drug, to the chemical blocking therapy, a sort of liver cancer therapy, which was regis...
KFDA to elect 18 companies as the best self-quality control practice.
18 drug companies including Handok, Boehringer Ingelheim Korea, Yuhan Kimberly, Dong-A, Chongkundang and Keunwha have been appointed as the best self-quality control practice.
Daejon regional KFDA appointed 18 drug...
Withpharm to distribute Edom cosmetics exclusively.
Withpharm, a pharmacy chain franchise company, has exerted their best efforts for the stable management of retail pharmacy business by promoting the OTC products and will sell a foreign brand of cosmetics under the ex...
RexGene Biotech to patent a formula for anti-cholesterol.
RexGene Biotech announced that the formula containing an extract of Sophorae fructus was registered to the Patent Office for the prevention and treatment of hyperlipidemia, arteriosclerosis and fat liver diseases.
...
Norvasc to get 29% market shares of Calcium blockers in 3QPfizer Korea's Norvasc (amlodipine besylate), an antihypertension drug, has achieved a successful sale of this year, showing the top place at about 41% of market shares out of t...
|
Only 10% of 2 million of climacteric male on therapy.
Hanmi recently held a symposium, ISA2005 (Symposium on international male climacteric) for the specialized doctors in endocrinology, urology and home medicine to promote Testo gel, a topical testosterone preparation.
...
Time for pharmacy nighttime extra charge returned to 6 p.m.
Health Insurance Policy Review Commission determined in the 19th regular meeting that the time for the medical institutions and pharmacies to charge their night time extra services should be returned to 6 p.m. again f...
130 billion won of budget for R&D of health and medical industry.
The government allocated about 123,197 million won of R&D budget for the health and medical technology development in 2006, about 20% increase or 19,900 million more to that of 2005, which included about 7 billion won...
KFDA tough supervising distribution of biological drugs.
The distribution controls seem to be intensified to the manufacturers and retail and wholesalers of biological preparations, especially focusing on 22 checking items including temperature controls, shipment certifica...
Kuhnil to agree with Kyorin for exclusive distribution of Ketas eye drop.
Kuhnil signed an agreement for the exclusive distribution of Ketas eye drop in Korea with Japanese Kyorin Pharm. Co. on Nov. 30.
Kyorin is a global research centered pharmaceutical company in Japan, especially in t...
